NCT06263543
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06263543
Title Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC (SERIES)
Acronym SERIES
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Reshma L. Mahtani, D.O.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Jonsson Comprehensive Cancer Center NOT_YET_RECRUITING Los Angeles California 90404 United States Details
Miami Cancer Institute at Baptist Health, Inc. RECRUITING Miami Florida 33176 United States Details
Winship Cancer Institute at Emory University RECRUITING Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field